By Dr Chung-Liang Shih For decades, hepatitis C has been recognised as a major global public health challenge, with an estimated 58 million people living with chronic hepatitis C infection worldwide. Although no vaccine currently exists, hepatitis C is now curable with highly effective direct-acting antiviral (DAA) therapies delivered through treatment courses of 8–12 weeks. … Continue reading Delivering on the WHO Vision: Taiwan’s path toward ending Hepatitis C as a public health threat
Copy and paste this URL into your WordPress site to embed
Delivering on the WHO Vision: Taiwan’s path toward ending Hepatitis C as a public health threat
By Dr Chung-Liang Shih For decades, hepatitis C has been recognised as a major global public health challenge, with an estimated 58 million people living with chronic hepatitis C infection worldwide. Although no vaccine currently exists, hepatitis C is now curable with highly effective direct-acting antiviral (DAA) therapies delivered through treatment courses of 8–12 weeks. … Continue reading Delivering on the WHO Vision: Taiwan’s path toward ending Hepatitis C as a public health threat